Improving AI tools for interpreting prostate MRI scans
Integrating Radiologist Insights for Safe and Accurate AI-Assisted Prostate MRI Interpretation
['FUNDING_R21'] · UNIVERSITY OF DELAWARE · NIH-11116549
This study is working on improving AI tools that help doctors read prostate MRI scans better, which is important for diagnosing prostate cancer, so that patients can get more accurate results and better care.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF DELAWARE (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-11116549 on ClinicalTrials.gov |
What this research studies
This research aims to enhance artificial intelligence (AI) tools used in interpreting prostate MRI scans, which are crucial for diagnosing prostate cancer. By integrating insights from radiologists and utilizing standardized reporting formats, the project seeks to train AI systems to better understand and analyze MRI images. The approach involves making radiology reports machine-readable and combining them with visual data to improve AI accuracy. This could lead to more reliable interpretations of MRI scans, ultimately benefiting patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are men undergoing MRI scans for prostate cancer diagnosis or monitoring.
Not a fit: Patients who are not undergoing MRI scans or those with prostate cancer that is not being evaluated through imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and reliable AI-assisted interpretations of prostate MRI scans, improving early detection and treatment of prostate cancer.
How similar studies have performed: Other research has shown promise in integrating AI with medical imaging, but this specific approach of combining radiologist insights with AI for prostate MRI interpretation is relatively novel.
Where this research is happening
Newark, UNITED STATES
- UNIVERSITY OF DELAWARE — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PENG, XI — UNIVERSITY OF DELAWARE
- Study coordinator: PENG, XI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.